Annual Results/Quarter Results Strong 2024 performance reflects Straumann Group’s strengths in innovation and execution 19-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Negotiations for the second phase of the Gaza ceasefire deal “will happen this week”, Israeli Foreign Minister Gideon Saar ...

Negotiations for the second phase of the Gaza ceasefire deal “will happen this week”, Israeli Foreign Minister Gideon Saar ...